| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1045576878 |
| P356 | DOI | 10.1186/1471-2407-13-40 |
| P932 | PMC publication ID | 3563620 |
| P698 | PubMed publication ID | 23369128 |
| P5875 | ResearchGate publication ID | 235390010 |
| P50 | author | Michael Pfreundschuh | Q1928879 |
| Ingolf Juhasz-Boess | Q38297180 | ||
| P2093 | author name string | Rainer Maria Bohle | |
| Stefan Graeber | |||
| Gunter Assmann | |||
| Erich Franz Solomayer | |||
| Frank Gruenhage | |||
| Jasmin Teresa Ney | |||
| P2860 | cites work | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
| A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 | ||
| RANK is essential for osteoclast and lymph node development | Q24598872 | ||
| osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification | Q24603266 | ||
| Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer | Q24605866 | ||
| Genome-wide association study identifies novel breast cancer susceptibility loci | Q24645441 | ||
| Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 | ||
| Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 | ||
| The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development | Q28142247 | ||
| RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis | Q28294501 | ||
| A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer | Q28303909 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer | Q28924377 | ||
| Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility | Q28943457 | ||
| Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies | Q29614869 | ||
| Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand | Q29619331 | ||
| Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study | Q30427359 | ||
| Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women | Q33223040 | ||
| Association between osteoprotegerin gene polymorphism and bone mineral density in patients with adolescent idiopathic scoliosis | Q33972264 | ||
| Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin | Q33981705 | ||
| 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. | Q34006369 | ||
| Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development | Q34091855 | ||
| "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density". | Q34106682 | ||
| Association between breast cancer laterality and tumor location, United States, 1994-1998. | Q34549676 | ||
| Cancer and laterality: a study of the five major paired organs (UK). | Q34566741 | ||
| Clinical features of metastatic bone disease and risk of skeletal morbidity | Q34576366 | ||
| Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer | Q34631785 | ||
| Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study | Q34865460 | ||
| Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium | Q35166701 | ||
| Influence of polymorphisms in the RANKL/RANK/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men. | Q35549417 | ||
| RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis | Q35885679 | ||
| Reproductive aging-associated common genetic variants and the risk of breast cancer | Q36245573 | ||
| Lung cancer. A statistical study based on autopsy data from 1928 to 1972 | Q36849237 | ||
| Association analyses suggest the effects of RANK and RANKL on age at menarche in Chinese women. | Q36928773 | ||
| Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic charcot neuroarthropathy: a case-control study | Q37319080 | ||
| Breast cancer genome-wide association studies: there is strength in numbers | Q37945448 | ||
| Unilateral breast-feeding and breast cancer | Q39442663 | ||
| Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically. | Q40296427 | ||
| Regulation of cancer cell migration and bone metastasis by RANKL. | Q40298349 | ||
| Laterality, maldescent, trauma and other clinical factors in the epidemiology of testis cancer in Victoria, Australia | Q42373213 | ||
| Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function | Q42446964 | ||
| Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study | Q42829926 | ||
| The relationship between Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) gene polymorphism and aortic calcification in Korean women | Q43079237 | ||
| Associations between HLA-DRB1, RANK, RANKL, OPG, and IL-17 genotypes and disease severity phenotypes in Japanese patients with early rheumatoid arthritis | Q43476748 | ||
| Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw. | Q43844827 | ||
| Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures | Q44049677 | ||
| Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women | Q44472863 | ||
| Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand | Q44534331 | ||
| Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men. | Q45298906 | ||
| Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases | Q45814967 | ||
| Breast size, handedness and breast cancer risk | Q47436720 | ||
| Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios | Q48003835 | ||
| Sleep on the right side-Get cancer on the left? | Q48392795 | ||
| Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. | Q50674084 | ||
| Genetic variation in the TNFRSF11A gene encoding RANK is associated with susceptibility to Paget's disease of bone. | Q51558602 | ||
| Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma. | Q52952110 | ||
| TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women. | Q53774658 | ||
| Genetic variations in the genes encoding receptor activator nuclear factor κ B (RANK), receptor activator nuclear factor κ B ligand (RANKL) and osteoprotegerin (OPG) in patients with psoriasis and psoriatic arthritis: a case-control study. | Q54385952 | ||
| The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women. | Q54674721 | ||
| Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men | Q57322613 | ||
| Evidence for a link between TNFRSF11A and risk of breast cancer | Q57881796 | ||
| Effects of denosumab on bone turnover markers in postmenopausal osteoporosis | Q58970691 | ||
| Genetic Variations in Genes Encoding RANK, RANKL, and OPG in Rheumatoid Arthritis: A Case-Control Study | Q60689128 | ||
| Renal cell carcinoma in New Zealand: a national survival study | Q72308380 | ||
| Functional analysis of a mutation occurring between the two in-frame AUG codons of human angiotensinogen | Q73236814 | ||
| Is A163G polymorphism in the osteoprotegerin gene associated with heel velocity of sound in postmenopausal women? | Q80691857 | ||
| Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women | Q80712478 | ||
| Expression of receptor activator of nuclear factor-kappaB is inversely correlated with metastatic phenotype in breast carcinoma | Q81321200 | ||
| Osteoprotegerin genetic polymorphisms and age of symptom onset in ankylosing spondylitis | Q82047826 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 40 | |
| P577 | publication date | 2013-01-31 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Genetic polymorphism of the OPG gene associated with breast cancer | |
| P478 | volume | 13 |
| Q35133898 | Evaluation of rs3102735 and rs2073617 Osteoprotegerin Gene Polymorphisms and the Risk of Childhood Acute lymphoblastic Leukemia in Zahedan Southeast Iran |
| Q48799956 | Genetic association and altered gene expression of osteoprotegerin in otosclerosis patients |
| Q34998448 | Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis |
| Q28081803 | Osteoprotegerin in breast cancer: beyond bone remodeling |
| Q26748804 | Osteoprotegerin rich tumor microenvironment: implications in breast cancer |
| Q92134531 | Osteoprotegerin: Relationship to Breast Cancer Risk and Prognosis |
| Q42013702 | Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patients |
| Q33895612 | RANK rs1805034 T>C polymorphism is associated with susceptibility of esophageal cancer in a Chinese population |
| Q53807792 | The association between RANKL and Osteoprotegerin gene polymorphisms with breast cancer. |
| Q37520235 | The prognostic role of RANK SNP rs34945627 in breast cancer patients with bone metastases. |
Search more.